UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Grows Holdings in Trupanion, Inc. (NASDAQ:TRUP)

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its stake in shares of Trupanion, Inc. (NASDAQ:TRUP - Free Report) by 14.2% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 89,184 shares of the financial services provider's stock after acquiring an additional 11,119 shares during the quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned about 0.21% of Trupanion worth $4,299,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently modified their holdings of TRUP. Barclays PLC increased its stake in shares of Trupanion by 259.2% during the 3rd quarter. Barclays PLC now owns 65,498 shares of the financial services provider's stock valued at $2,750,000 after acquiring an additional 47,262 shares during the last quarter. KBC Group NV acquired a new position in shares of Trupanion during the 4th quarter valued at about $75,000. Choreo LLC acquired a new position in shares of Trupanion during the 4th quarter valued at about $201,000. Baillie Gifford & Co. increased its stake in shares of Trupanion by 26.6% during the 4th quarter. Baillie Gifford & Co. now owns 701,366 shares of the financial services provider's stock valued at $33,806,000 after acquiring an additional 147,341 shares during the last quarter. Finally, Principal Financial Group Inc. increased its stake in shares of Trupanion by 3.4% during the 4th quarter. Principal Financial Group Inc. now owns 163,188 shares of the financial services provider's stock valued at $7,866,000 after acquiring an additional 5,412 shares during the last quarter.

Trupanion Trading Up 4.0%

TRUP traded up $1.88 on Friday, reaching $49.46. 363,283 shares of the company's stock were exchanged, compared to its average volume of 610,959. The company's 50 day moving average is $41.00 and its 200-day moving average is $43.78. The company has a market cap of $2.12 billion, a price-to-earnings ratio of -215.04, a PEG ratio of 6.02 and a beta of 1.81. Trupanion, Inc. has a twelve month low of $25.90 and a twelve month high of $57.90. The company has a debt-to-equity ratio of 0.39, a quick ratio of 1.66 and a current ratio of 1.71.

Trupanion (NASDAQ:TRUP - Get Free Report) last posted its earnings results on Thursday, May 1st. The financial services provider reported ($0.03) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.05) by $0.02. Trupanion had a negative net margin of 0.75% and a negative return on equity of 3.08%. The firm had revenue of $341.98 million during the quarter, compared to the consensus estimate of $337.81 million. During the same quarter in the prior year, the company earned ($0.16) EPS. The company's revenue was up 11.7% on a year-over-year basis. Equities analysts predict that Trupanion, Inc. will post 0.13 earnings per share for the current year.

Insider Buying and Selling at Trupanion

In other Trupanion news, CEO Margaret Tooth sold 4,000 shares of the stock in a transaction that occurred on Thursday, March 20th. The shares were sold at an average price of $37.17, for a total value of $148,680.00. Following the completion of the sale, the chief executive officer now owns 118,784 shares of the company's stock, valued at $4,415,201.28. This trade represents a 3.26% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Fawwad Qureshi sold 828 shares of the stock in a transaction that occurred on Tuesday, May 27th. The shares were sold at an average price of $45.53, for a total transaction of $37,698.84. Following the completion of the sale, the chief financial officer now directly owns 6,079 shares of the company's stock, valued at $276,776.87. This trade represents a 11.99% decrease in their position. The disclosure for this sale can be found here. Insiders sold 19,362 shares of company stock valued at $817,196 over the last 90 days. 5.42% of the stock is owned by corporate insiders.

Analyst Ratings Changes

A number of research firms have recently commented on TRUP. Stifel Nicolaus dropped their price objective on shares of Trupanion from $44.00 to $41.00 and set a "hold" rating for the company in a research note on Thursday, February 20th. Lake Street Capital dropped their target price on shares of Trupanion from $65.00 to $60.00 and set a "buy" rating for the company in a research report on Friday, May 2nd. Finally, Piper Sandler dropped their target price on shares of Trupanion from $57.00 to $52.00 and set an "overweight" rating for the company in a research report on Thursday, February 20th. Two analysts have rated the stock with a hold rating, four have issued a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $51.80.

Trupanion Company Profile

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.